When is it useful to test for multiple amyloid-related biomarkers for patients undergoing work-up for cognitive impairment?

E.g., amyloid PET, CSF amyloid, blood-based amyloid.

Answer from: at Academic Institution

If a patient has a presentation consistent with MCI or early dementia due to AD (slow progressive decline, STM loss, no hallucinations, no neuro deficits), I will get an MRI and amyloid blood-based biomarkers. If the goal is just a diagnosis, I stop there. If they are interested in “mab”...

Comments

at Cedar Centre Psychiatric Group
Does insurance cover the blood work?

at Wake Forest University School of Medicine
Yes, with a diagnosis of Alzheimer’s Disease...

at Private Pratice
Which biomarkers do you order?

at Wake Forest University School of Medicine
This is a moving target. First, it was the PTau 18...

Please select the option that best describes you:

When is it useful to test for multiple amyloid-related biomarkers for patients undergoing work-up for cognitive impairment?

Related Questions